These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 68Ga-DOTATATE and 68Ga-NODAGA-JR11 PET/CT Images in a Patient With Gastric Neuroendocrine Tumor. Lin Z; Lin R; Zhang J; Yao S; Miao W Clin Nucl Med; 2021 Oct; 46(10):853-855. PubMed ID: 34034328 [TBL] [Abstract][Full Text] [Related]
4. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms. Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939 [TBL] [Abstract][Full Text] [Related]
5. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification. Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222 [TBL] [Abstract][Full Text] [Related]
6. 68Ga-DOTATATE PET/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor. Alabed YZ Clin Nucl Med; 2023 Feb; 48(2):e78-e79. PubMed ID: 36607378 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077 [TBL] [Abstract][Full Text] [Related]
8. 68Ga-DOTATATE Uptake in an Intraosseous Hemangioma, as a Potential Cause of False-Positive PET/CT Finding, Simulating Tumoral Involvement. Saidi B; Fallahi B; Manafi-Farid R; Fard-Esfahani A; Eftekhari M Clin Nucl Med; 2022 Mar; 47(3):e274-e275. PubMed ID: 35025790 [TBL] [Abstract][Full Text] [Related]
9. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease. Sharma A; Navaz AJ; Pandey MK; Parent EE Clin Nucl Med; 2022 Feb; 47(2):137-139. PubMed ID: 34690295 [TBL] [Abstract][Full Text] [Related]
10. [Detection of neuroendocrine tumors by positron emission tomography-computed tomography with 68Ga-DOTATATE: report of one case]. Amaral H; Pruzzo R; Redondo F; Gil MC; Pizarro A; de la Fuente H; Butte JM; Coudeu TM Rev Med Chil; 2009 Apr; 137(4):537-41. PubMed ID: 19623420 [TBL] [Abstract][Full Text] [Related]
11. 68Ga-FAPI PET/CT Versus 68Ga-DOTATATE PET/CT in the Evaluation of a Patient With Neuroendocrine Tumor. Kömek H; Gündoğan C; Can C Clin Nucl Med; 2021 May; 46(5):e290-e292. PubMed ID: 33351508 [TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Jackson T; Darwish M; Cho E; Nagatomo K; Osman H; Jeyarajah DR Abdom Radiol (NY); 2021 Jul; 46(7):3179-3183. PubMed ID: 33665733 [TBL] [Abstract][Full Text] [Related]